This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Bayer Healthcare LLC, Crispr Therapeutics Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 789 
1 out of 86 
Years Active: 2025
Title: The Innovations of Caroline W. Reiss
Introduction
Caroline W. Reiss is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of genetic engineering, particularly through her innovative work on RNA-programmable endonuclease systems. Her research focuses on novel systems for targeting, editing, or manipulating DNA within cells.
Latest Patents
Caroline holds a patent for "RNA-programmable endonuclease systems and uses thereof." This invention relates to the development of synthetic RNA-guided nucleases (sRGNs) derived from wildtype or parental small type II CRISPR Cas9 endonucleases. The implications of her work are vast, offering new avenues for genetic manipulation and therapeutic applications.
Career Highlights
Throughout her career, Caroline has worked with notable companies such as Crispr Therapeutics AG and Bayer Healthcare LLC. Her expertise in the field has positioned her as a key player in advancing genetic research and technology.
Collaborations
Caroline has collaborated with esteemed colleagues, including Andre Cohnen and Moritz Schmidt, further enhancing the impact of her work in the scientific community.
Conclusion
Caroline W. Reiss is a trailblazer in the field of genetic engineering, with her innovative patents and collaborations paving the way for future advancements in DNA manipulation. Her contributions continue to influence the landscape of biotechnology and genetic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile